Author

Liujia Qian

Westlake UniversityORCID 0000-0002-0870-7479Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 3 Approach:statistical model· 3 Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Research Focus:database / resource· 1 Approach:deep learning· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Tiannan GuoiD· 3 shared Zhangzhi XueiD· 2 shared A Jun· 1 shared Cheng ZhangiD· 1 shared Cong LuiD· 1 shared Connie R. JiméneziD· 1 shared E WeinaniD· 1 shared Fangfei ZhangiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioinformatics

Tiannan GuoORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioinformaticsbioRxivPreprintJun 22, 2026

Drug-Prot: A query system for statistical inference of drug effects and interactions in dynamic proteomic networks

Markus Ulmer, Rui Sun, Liujia Qian…·Peter Bühlmann

Drug-Prot quantifies drug effects and interactions using proteomic data, revealing protein-level causal relationships and actionable drug combinations.

DOI 10.64898/2026.06.17.732914

humanproteomics

𝕏 PostBluesky

Systems BiologybioRxivPreprintFeb 7, 2025

A perturbation proteomics-based foundation model for virtual cell construction

Rui Sun, Liujia Qian, Yongge Li…·Tiannan Guo

The paper develops a foundation model using perturbation proteomics data to predict drug responses and improve breast cancer prognosis.

10 citations

humanproteomics

𝕏 PostBluesky

BioinformaticsbioRxivPreprintJan 7, 2023

DPHL v2: An updated and comprehensive DIA pan-human assay library for quantifying more than 14,000 proteins.

Zhangzhi Xue, Tiansheng Zhu, Fangfei Zhang…·Tiannan Guo

DPHL v2 improves upon DPHL v1 by including semi-tryptic peptides and protein isoforms, increasing identified and dysregulated proteins in colorectal cancer analysis.

DOI 10.1101/2023.01.07.523067

humanproteomics

𝕏 PostBluesky